Related Experiment Video
Updated: Sep 20, 2026

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
[Regression of left ventricular mass in arterial hypertension. Efficacy of 3 different treatment protocols]
J R González-Juanatey1, A Amaro Cendón, C Calvo Gómez
1Unidad Coronaria, Hospital Xeral de Galicia, Facultad de Medicina, Santiago de Compostela, La Coruña.
Insights
Atenolol and enalapril demonstrated superior antihypertensive efficacy during exercise compared to chlorthalidone. Both atenolol and enalapril effectively reduced left ventricular mass in hypertensive patients.
Area of Science:
- Cardiology
- Pharmacology
- Hypertension Research
Background:
- Hypertension poses a significant risk factor for cardiovascular disease.
- Left ventricular mass is a key indicator of cardiac remodeling in hypertensive individuals.
Purpose of the Study:
- To compare the antihypertensive efficacy of chlorthalidone, atenolol, and enalapril at rest and during exercise.
- To assess the impact of these antihypertensive drugs on left ventricular mass.
Main Methods:
- A study involving 50 hypertensive males (mean age 51 years) treated with chlorthalidone (n=15), atenolol (n=20), or enalapril (n=15).
- Blood pressure and echocardiograms were recorded at baseline and at 3, 6, and 9 months.
- Interventricular septum thickness, posterior left ventricular wall thickness, and left ventricular mass index were measured.
Main Results:
- All three drugs showed similar antihypertensive efficacy at rest.
- Atenolol and enalapril exhibited superior efficacy during exercise compared to chlorthalidone.
- Significant reductions in interventricular septum thickness, posterior left ventricular wall, and left ventricular mass index were observed with atenolol and enalapril.
Conclusions:
- Atenolol and enalapril are more effective than chlorthalidone in managing exercise-induced hypertension.
- Atenolol and enalapril effectively induce regression of left ventricular mass, suggesting a cardioprotective effect.
Background:
To evaluate the antihypertensive efficacy, at rest and under exercise, in patients treated with three different antihypertensive drugs and the modifications induced on the left ventricular mass.
Methods:
Fifty hypertensive males, mean age 51 years, 15 received 50 mg/day of chlorthalidone, 20 atenolol (100 mg/day) and 15 enalapril (20-40 mg/day). Baseline pressure control and echocardiogram, and 3, 6 and 9 months after starting therapy were performed. Thickness of the interventricular septum and posterior left ventricular wall in mm, left ventricular mass index in g/m2 were determined.
Results:
The baseline septum in the diuretic group was 15 +/- 3 mm and 14 +/- 3 mm at 9 months, in the atenolol group was 16 +/- 3 mm and 12 +/- 2 mm (p less than 0.001), and in the enalapril group 15 +/- 2 mm and 12 +/- 3 mm (p less than 0.01). The posterior wall was 14 +/- 3 mm and 13 +/- 2 mm in the diuretic group, in the atenolol group 15 +/- 2 mm and 12 +/- 2 mm (p less than 0.001) and in the enalapril group 15 +/- 2 mm and 12 +/- 3 mm (p less than 0.01). The left ventricular mass index was in he diuretic group 153 +/- 45 g/m2 and 146 +/- 36 g/m2, in the atenolol group 167 +/- 34 g/m2 and 128 +/- 24 g/m2 (p less than 0.001) and in the enalapril group 156 +/- 36 g/m2 and 131 +/- 26 g/m2 (p less than 0.05).
Conclusions:
The antihypertensive efficacy at rest was similar with the three drugs, being under exercise superior atenolol and enalapril. Only atenolol and enalapril induced regression of left ventricular mass.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Mitral Regurgitation III: Medical Management
Aortic Regurgitation III: Medical Management
Heart Failure V: Medical Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis III: Management

